Home/Filings/4/0001933414-25-000017
4//SEC Filing

Catalys Pacific Fund, LP 4

Accession 0001933414-25-000017

CIK 0001933414other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 6:59 PM ET

Size

12.3 KB

Accession

0001933414-25-000017

Insider Transaction Report

Form 4
Period: 2025-02-13
Transactions
  • Other

    Stock Option

    2025-02-1332,9000 total
    Exercise: $10.20Exp: 2035-02-13Common Stock (32,900 underlying)
  • Other

    Stock Option

    2025-02-13+32,90032,900 total(indirect: See footnote)
    Exercise: $10.20Exp: 2035-02-13Common Stock (32,900 underlying)
  • Award

    Stock Option

    2025-02-13+32,90032,900 total
    Exercise: $10.20Exp: 2035-02-13Common Stock (32,900 underlying)
Slingsby Brian Taylor
Director10% Owner
Transactions
  • Other

    Stock Option

    2025-02-13+32,90032,900 total(indirect: See footnote)
    Exercise: $10.20Exp: 2035-02-13Common Stock (32,900 underlying)
  • Award

    Stock Option

    2025-02-13+32,90032,900 total
    Exercise: $10.20Exp: 2035-02-13Common Stock (32,900 underlying)
  • Other

    Stock Option

    2025-02-1332,9000 total
    Exercise: $10.20Exp: 2035-02-13Common Stock (32,900 underlying)
Footnotes (3)
  • [F1]The stock option vests in 12 substantially equal monthly installments following the date of grant.
  • [F2]Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP.
  • [F3]Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Issuer

Mineralys Therapeutics, Inc.

CIK 0001933414

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001746274

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:59 PM ET
Size
12.3 KB